Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 8/20 | 0.60 |
| ▸ | DPP8 | Q6V1X1 | 5/20 | 0.60 |
| ▸ | DPP9 | Q86TI2 | 4/20 | 0.60 |
| ▸ | FAP | Q12884 | 1/20 | 0.60 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.60 |
| ▸ | ACE | P12821 | 4/20 | 0.51 |
| ▸ | ANPEP | P15144 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL825679 | 1.00 | DPP4 (0.60) | DPP4DPP8DPP9FAPDPP7 | |
| SCHEMBL29565533 | 1.00 | DPP4 (0.60) | DPP4DPP8DPP9FAPDPP7 | |
| SCHEMBL27902671 | 1.00 | DPP4 (0.60) | DPP4DPP8DPP9FAPDPP7 | |
| SCHEMBL29356868 | 1.00 | DPP4 (0.60) | DPP4DPP8DPP9FAPDPP7 | |
| SCHEMBL6371844 | 1.00 | DPP4 (0.60) | DPP4DPP8DPP9FAPDPP7 | |
| Hydrochloric Acid SCHEMBL29415382 | 0.98 | DPP4 (0.59) | DPP4DPP8DPP9FAPDPP7 | |
| SCHEMBL10658318 | 0.98 | DPP4 (0.59) | DPP4DPP8DPP9FAPDPP7 | |
| Bromide SCHEMBL11865608 | 0.98 | DPP4 (0.59) | DPP4DPP8DPP9FAPDPP7 | |
| SCHEMBL10658327 | 0.98 | DPP4 (0.59) | DPP4DPP8DPP9FAPDPP7 | |
| Bromide SCHEMBL11865615 | 0.98 | DPP4 (0.59) | DPP4DPP8DPP9FAPDPP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250026787-A1 | PEPTIDES AND METHODS FOR REDUCING SKIN PIGMENTATION | GLO PHARMA, INC. | 2025-01-23 | — | — | US | claimed |
| US-20250026787-A1 | PEPTIDES AND METHODS FOR REDUCING SKIN PIGMENTATION | GLO PHARMA, INC. | 2025-01-23 | — | — | US | disclosed |
| US-12162956-B2 | Peptides and methods for reducing skin pigmentation | GLO PHARMA, INC. (US) | 2024-12-10 | — | — | US | disclosed |
| US-20240190917-A1 | PEPTIDES AND METHODS FOR REDUCING SKIN PIGMENTATION | GLO PHARMA, INC. | 2024-06-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240190917-A1 | PEPTIDES AND METHODS FOR REDUCING SKIN PIGMENTATION | MC1R, TYR, MC5R | DPP4 736/4885DPP8 196/4885DPP9 170/4885 |
| US-12162956-B2 | Peptides and methods for reducing skin pigmentation | MC1R, TYR, MC5R | DPP4 736/4885DPP8 196/4885DPP9 170/4885 |
| US-20250026787-A1 | PEPTIDES AND METHODS FOR REDUCING SKIN PIGMENTATION | MC1R, TYR, MC5R | DPP4 736/4885DPP8 196/4885DPP9 170/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.